Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis
Targeting self-renewing cancer cells without deleterious side effects in normal tissues has proven challenging. Here, the authors show that the well-tolerated HDAC inhibitor Quisinostat safely inhibits tumor maintenance and disease relapse by restoring high levels of histone H1.0.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f8d840aac93c41c6937b76b29e6d3cbc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|